The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 27, 2012
Filed:
Jun. 01, 2007
John C. Byrd, Arlington, OH (US);
Danilo Perrotti, Dublin, OH (US);
Ching-shih Chen, Upper Arlington, OH (US);
James T. Dalton, Lakeland, TN (US);
Frank Frissora, Columbus, OH (US);
Xiaobin Zhao, Columbus, OH (US);
Qing Liu, Rockville, MD (US);
Natarajan Muthusamy, Galloway, OH (US);
John C. Byrd, Arlington, OH (US);
Danilo Perrotti, Dublin, OH (US);
Ching-Shih Chen, Upper Arlington, OH (US);
James T. Dalton, Lakeland, TN (US);
Frank Frissora, Columbus, OH (US);
Xiaobin Zhao, Columbus, OH (US);
Qing Liu, Rockville, MD (US);
Natarajan Muthusamy, Galloway, OH (US);
The Ohio State University Research Foundation, Columbus, OH (US);
Abstract
Methods—for treatment and prevention of lymphoid malignancies, including, but not limited to acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), B-cell lymphoma, Acute Myeloid leukemia (AML), and mantle cell lymphoma (MCL). The methods include administration of a therapeutically effective amount of FTY720 (2-Amino-2-[2-(4-octylphenyl)ethyl]propane 1,3-diol hydrochloride) or a derivative, pharmaceutically acceptable salt thereof, or a prodrug thereof to a subject.